Which agents are 5-alpha-reductase inhibitors used in BPH?

Study for the PANCE Precision Exam. Improve with flashcards and multiple choice questions, each question has hints and explanations. Get ready for your exam!

Multiple Choice

Which agents are 5-alpha-reductase inhibitors used in BPH?

Explanation:
5-alpha-reductase inhibitors in BPH work by blocking the conversion of testosterone to dihydrotestosterone, a hormone that drives prostate growth. The drugs that do this are finasteride and dutasteride. Finasteride mainly inhibits type II 5-alpha-reductase, while dutasteride inhibits both type I and II, causing a gradual reduction in prostate size and improvement in urinary symptoms over months. They’re not for rapid relief; alpha-1 blockers provide quicker symptom relief by relaxing smooth muscle but don’t shrink the gland. PDE-5 inhibitors aren’t 5-alpha-reductase inhibitors, though they can help BPH symptoms in some contexts. So the agents that are 5-alpha-reductase inhibitors used in BPH are finasteride and dutasteride.

5-alpha-reductase inhibitors in BPH work by blocking the conversion of testosterone to dihydrotestosterone, a hormone that drives prostate growth. The drugs that do this are finasteride and dutasteride. Finasteride mainly inhibits type II 5-alpha-reductase, while dutasteride inhibits both type I and II, causing a gradual reduction in prostate size and improvement in urinary symptoms over months. They’re not for rapid relief; alpha-1 blockers provide quicker symptom relief by relaxing smooth muscle but don’t shrink the gland. PDE-5 inhibitors aren’t 5-alpha-reductase inhibitors, though they can help BPH symptoms in some contexts. So the agents that are 5-alpha-reductase inhibitors used in BPH are finasteride and dutasteride.

Subscribe

Get the latest from Passetra

You can unsubscribe at any time. Read our privacy policy